• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JYSB2200098 乌司奴单抗注射液 ustekinumab Injection Biological Products Supplementary Application 2022-06-16 Cilag AG;Janssen-Cilag International NV view
JYSB2500092 乌司奴单抗注射液 ustekinumab Injection Biological Products Supplementary Application 2025-04-03 Cilag AG;Janssen-Cilag International NV view
JYSB2200131 乌司奴单抗注射液 ustekinumab Injection Biological Products Supplementary Application 2022-07-20 Cilag AG;Janssen-Cilag International NV view
JYSB2300220 乌司奴单抗注射液 ustekinumab Injection Biological Products Supplementary Application 2023-12-20 Cilag AG;Janssen-Cilag International NV view
JYSB2101094 乌司奴单抗注射液(静脉输注) ustekinumab Injection Biological Products Supplementary Application 2021-07-27 Cilag AG;Janssen-Cilag International NV view
CXSS2400130 乌司奴单抗注射液 ustekinumab Injection Biological Products(3.3) New Drug Application 2024-11-26 CSPC Megalith Biopharmaceutical Co Ltd view
JYSB2200101 乌司奴单抗注射液 ustekinumab Injection Biological Products Supplementary Application 2022-06-20 Cilag AG;Janssen-Cilag International NV view
JYSB2300042 乌司奴单抗注射液(静脉输注) ustekinumab Injection Biological Products Supplementary Application 2023-03-07 Cilag AG;Janssen-Cilag International NV view
JYSZ2400052 乌司奴单抗注射液(静脉输注) ustekinumab Injection Biological Products License Renew 2024-09-07 Xian Janssen Pharmaceutical Ltd;Cilag AG;Janssen-Cilag International NV view
JYSB2200099 乌司奴单抗注射液(静脉输注) ustekinumab Injection Biological Products Supplementary Application 2022-06-16 Cilag AG;Janssen-Cilag International NV view
CXSS2300065 乌司奴单抗注射液 ustekinumab Injection Biological Products(3.3) New Drug Application 2023-08-12 Jiangsu Saifushi Biotechnology Co Ltd;Hangzhou Zhongmei Huadong Pharmaceutical Co Ltd view
JYSB2400230 乌司奴单抗注射液(静脉输注) ustekinumab Injection Biological Products Supplementary Application 2024-10-17 Cilag AG;Janssen-Cilag International NV view
JYSB2200097 乌司奴单抗注射液 ustekinumab Injection Biological Products Supplementary Application 2022-06-16 Cilag AG;Janssen-Cilag International NV view
JYSB2300043 乌司奴单抗注射液 ustekinumab Injection Biological Products Supplementary Application 2023-03-07 Cilag AG;Janssen-Cilag International NV view
CXSS2400048 乌司奴单抗注射液 ustekinumab Injection Biological Products(3.3) New Drug Application 2024-05-09 Bio-Thera Solutions Ltd view
JYSB2200132 乌司奴单抗注射液 ustekinumab Injection Biological Products Supplementary Application 2022-07-20 Cilag AG;Janssen-Cilag International NV view
CXSS2500028 乌司奴单抗注射液(静脉输注) ustekinumab Injection Biological Products(3.3) New Drug Application 2025-02-12 Jiangsu Saifushi Biotechnology Co Ltd;Hangzhou Zhongmei Huadong Pharmaceutical Co Ltd view
JYSZ2300030 乌司奴单抗注射液 ustekinumab Injection Biological Products License Renew 2023-07-25 Cilag AG;Xian Janssen Pharmaceutical Ltd;Janssen-Cilag International NV view
JYSB2400229 乌司奴单抗注射液 ustekinumab Injection Biological Products Supplementary Application 2024-10-17 Cilag AG;Janssen-Cilag International NV view
JYSB2200100 乌司奴单抗注射液(静脉输注) ustekinumab Injection Biological Products Supplementary Application 2022-06-20 Cilag AG;Janssen-Cilag International NV view